This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA
Book Now
Menu
Book

Melissa Vasbinder, Ph.D
Head of Research at Mariana Oncology
Speaker

Agenda Sessions

  • Discovery of 225Ac-ETN029: A Peptide-based Radioligand Therapy for the Treatment of DLL3-expressing Solid Tumors

    , 5:15pm
    View Session

At this event

Prev
Next
Bharath Venkatram
Senior Engineer, Process Development & Scale Up La
Amgen

See Melissa at TIDES USA: Oligonucleotide & Peptide Therapeutics

Book Now